Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Keunpyo Kim
Observed name:
Keun Pyo Kim
Institution:
Editas Medicine (United States)
Observed institutions:
Massachusetts Eye and Ear Infirmary,
Children's Hospital of Philadelphia,
Harvard University,
University of Michigan,
Regenxbio (United States),
Editas Medicine (United States),
University of Pennsylvania,
Virginia Tech,
PRA Health Sciences
show all 9
ORCID:
0000-0002-7103-924X
Observed ORCID:
0000-0002-7103-924X
OpenAlex ID:
A5041000924
On the Monitoring of Linear Profiles
2003
·
Keunpyo Kim
, Mahmoud A. Mahmoud
, et al.
·
Journal of Quality Technology
·
486
Gene Editing for CEP290 -Associated Retinal Degeneration
2024
·
Eric A. Pierce
, Tomas S. Aleman
, et al.
·
New England Journal of Medicine
·
275
PDF
A Comparative Lipidomics Platform for Chemotaxonomic Analysis of Mycobacterium tuberculosis
2011
·
Emilie Layre
, Lindsay Sweet
, et al.
·
Chemistry & Biology
·
209
PDF
A randomized trial of benralizumab, an antiinterleukin 5 receptor α monoclonal antibody, after acute asthma
2014
·
Richard M. Nowak
, Joseph M. Parker
, et al.
·
The American Journal of Emergency Medicine
·
207
A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma
2013
·
Chad K Oh
, Richard Leigh
, et al.
·
Respiratory Research
·
148
PDF
Pharmacokinetics, Pharmacodynamics, and Safety of MEDI4212, an Anti-IgE Monoclonal Antibody, in Subjects with Atopy: A Phase I Study
2016
·
Eric Sheldon
, Martin Schwickart
, et al.
·
Advances in Therapy
·
43
Multivariate Control Charts for Monitoring the Process Mean and Variability Using Sequential Sampling
2007
·
Marion R. Reynolds
, Keunpyo Kim
·
Sequential Analysis
·
32
Multivariate Monitoring of the Process Mean Vector with Sequential Sampling
2005
·
Marion R. Reynolds
, Keunpyo Kim
·
Journal of Quality Technology
·
32
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease
2026
·
Rabi Hanna
, Haydar Frangoul
, et al.
·
New England Journal of Medicine
·
29
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia
2026
·
Haydar Frangoul
, Rabi Hanna
, et al.
·
New England Journal of Medicine
·
26
Symmetric Age Association of Retinal Degeneration in Patients with CLN2-Associated Batten Disease
2020
·
Kyle D. Kovacs
, Samir Patel
, et al.
·
Ophthalmology Retina
·
25
PDF
Multivariate Monitoring Using an MEWMA Control Chart with Unequal Sample Sizes
2005
·
Keunpyo Kim
, Marion R. Reynolds
·
Journal of Quality Technology
·
22
AsCas12a Gene Editing of HBG1/2 Promoters with EDIT-301 Results in Rapid and Sustained Normalization of Hemoglobin and Increased Fetal Hemoglobin in Patients with Severe Sickle Cell Disease and Transfusion-Dependent Beta-Thalassemia
2023
·
Rabi Hanna
, Haydar Frangoul
, et al.
·
Blood
·
20
S264: Edit-301 Shows Promising Preliminary Safety and Efficacy Results in the Phase I/ii Clinical Trial (ruby) of Patients With Severe Sickle Cell Disease Using Highly Specific and Efficient Ascas12a Enzyme
2023
·
Rabi Hanna
, Haydar Frangoul
, et al.
·
HemaSphere
·
20
Reduction In The Number And Severity Of Exacerbations Following Acute Severe Asthma: Results Of A Placebo-Controlled, Randomized Clinical Trial With Benralizumab
2012
·
Nestor A. Molfino
, Richard Nowak
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
11
Long-term stability of nutrients in a frozen mixed food control material
2001
·
K. M. Phillips
, A. H. Simpkins
, et al.
·
Fresenius Journal of Analytical Chemistry
·
11
Twelve-month Natural History Study of Centrosomal Protein 290 (CEP290)-associated Inherited Retinal Degeneration
2024
·
Eric A. Pierce
, Bright S. Ashimatey
, et al.
·
Ophthalmology Science
·
8
PDF
AsCas12a Gene Editing of HBG1/2 Promoters with Edit-301 Results in Early and Sustained Normalization of Hemoglobin and Increased Fetal Hemoglobin in Patients with Severe Sickle Cell Disease and Transfusion-Dependent Beta-Thalassemia
2024
·
Haydar Frangoul
, Rabi Hanna
, et al.
·
Transplantation and Cellular Therapy
·
8
Reni-Cel, an Investigational AsCas12a Gene-Edited Cell Medicine, Led to Successful Engraftment, Increased Hemoglobin, and Reduced Transfusion Dependence in Patients with Transfusion-Dependent Beta-Thalassemia Treated in the Edithal Trial
2024
·
Haydar Frangoul
, Rabi Hanna
, et al.
·
Blood
·
5
A Phase 2b, Randomized Study To Evaluate The Clinical Activity And Safety Profile Of Subcutaneous MEDI-528, An Anti-IL-9 Monoclonal Antibody, In Adults With Uncontrolled Asthma
2012
·
Chad K. Oh
, Kimmie K. McLaurin
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
3
Reni-Cel, an Investigational AsCas12a Gene-Edited Cell Medicine, Led to Sustained Hemoglobin Normalization and Increased Fetal Hemoglobin in Patients with Severe Sickle Cell Disease Treated in the RUBY Trial
2025
·
Mark Walters
, Haydar Frangoul
, et al.
·
Transplantation and Cellular Therapy
·
2
Reni-Cel, an Investigational AsCas12a Gene-Edited Cell Medicine, Led to Successful Engraftment, Increased Hemoglobin, and Reduced Transfusion Dependence in Patients with Transfusion-Dependent Beta-Thalassemia Treated in the Edithal Trial
2025
·
Haydar Frangoul
, Rabi Hanna
, et al.
·
Transplantation and Cellular Therapy
·
2
Characteristics and 12-Week Outcomes for Marijuana Smokers in Subjects With Asthma Treated in the Emergency Department for an Asthma Exacerbatio
2012
·
Joseph Parker
, Keunpyo Kim
, et al.
·
CHEST Journal
·
1
Multivariate monitoring using an MEWMA control chart with unequal sample sizes
2006
·
Keunpyo Kim
, Marion R. Reynolds
·
Quality Engineering
·
1
Twelve-Week Clinical Outcomes Following an Emergency Department Asthma Visit
2012
·
Robert Silverman
, Keunpyo Kim
, et al.
·
CHEST Journal
Show more works
View as search
Works count:
26
Citation count:
1,626
H-index:
14
I10-index:
16
Year
Topic
Type